Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

258
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
258
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

392
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
392

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlling nanoparticle targeting: from physicochemical design to molecular recognition.

Nanomedicine (London, England)·2026
Same author

Gold decorated bismuth sulfide nanorods for enhanced computed tomography imaging with in vitro and in vivo validation.

Discover nano·2026
Same author

Programming Degradation and Drug Release Through Micropatterning of PLGA Films.

ACS applied materials & interfaces·2026
Same author

Congestion, Obesity, and Survival in Chronic Heart Failure.

Journal of cardiac failure·2026
Same author

A Decisive Decade for Cardiovascular Health in Africa: Turning Evidence into System Design.

Global heart·2026
Same author

Congestion and renal function in patients with chronic heart failure.

ESC heart failure·2026

Related Experiment Video

Updated: Oct 11, 2025

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.0K

Nanoparticle theranostics in cardiovascular inflammation.

Neil MacRitchie1, Valentina Di Francesco2, Miguel Filipe Moreira Marques Ferreira2

  • 1Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Seminars in Immunology
|December 4, 2021
PubMed
Summary
This summary is machine-generated.

Theranostics combines diagnostics and therapy using nanoparticles for targeted disease treatment. This review explores theranostic nanomedicine applications in cardiovascular inflammation imaging and therapy.

Keywords:
AtherosclerosisCardiovascular diseaseInflammationMyocardial infarctionNanoparticlesTheranostics

More Related Videos

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.5K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.1K

Related Experiment Videos

Last Updated: Oct 11, 2025

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.0K
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.5K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.1K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Molecular Imaging

Background:

  • Theranostics integrates diagnostic and therapeutic approaches.
  • Nanoparticles offer targeted delivery and multifunctionality for theranostic applications.

Purpose of the Study:

  • To review the current status of theranostic nanomedicine.
  • To highlight applications in cardiovascular inflammation.

Main Methods:

  • Literature review of theranostic nanomedicine.
  • Analysis of nanoparticle-based theranostic strategies.
  • Case studies on cardiovascular inflammation.

Main Results:

  • Nanoparticles are key components in theranostic systems.
  • Demonstrated potential in simultaneous diagnosis and treatment.
  • Specific examples in cardiovascular inflammation detailed.

Conclusions:

  • Theranostic nanomedicine shows significant promise for treating cardiovascular inflammation.
  • Nanoparticle-based approaches enable targeted imaging and therapy.
  • Further research is warranted to translate findings into clinical practice.